26-Dec-2025
(Exclusive) The Selloff In EDAP Looks Overdone
Seeking Alpha (Sun, 7-Feb 2:28 AM ET)
EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU
Globe Newswire (Thu, 20-Nov 7:30 AM ET)
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference
Globe Newswire (Tue, 18-Nov 7:00 AM ET)
EDAP Reports Third Quarter 2025 Financial Results
Globe Newswire (Thu, 6-Nov 7:30 AM ET)
EDAP to Present at Jefferies Global Healthcare Conference in London
Globe Newswire (Tue, 4-Nov 7:00 AM ET)
EDAP to Participate in the UBS Global Healthcare Conference
Globe Newswire (Mon, 27-Oct 7:00 AM ET)
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025
Globe Newswire (Thu, 23-Oct 7:00 AM ET)
Globe Newswire (Mon, 20-Oct 8:30 AM ET)
Focal One Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option
Globe Newswire (Tue, 30-Sep 7:00 AM ET)
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share trades on the NASDAQ stock market under the symbol EDAP.
As of December 26, 2025, EDAP stock price climbed to $3.40 with 105,765 million shares trading.
EDAP has a beta of 1.44, meaning it tends to be more sensitive to market movements. EDAP has a correlation of 0.07 to the broad based SPY ETF.
EDAP has a market cap of $126.15 million. This is considered a Micro Cap stock.
Last quarter Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share reported $16 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $988,000 and exceeded earnings estimates by $.10.
In the last 3 years, EDAP traded as high as $12.65 and as low as $1.21.
EDAP has outperformed the market in the last year with a price return of +59.6% while the SPY ETF gained +16.0%. EDAP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +40.5% and +18.1%, respectively, while the SPY returned +4.6% and +1.5%, respectively.
EDAP support price is $2.74 and resistance is $3.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDAP shares will trade within this expected range on the day.